Therapeutic potential of carbon monoxide in multiple sclerosis
about
Neurobehavioral burden of multiple sclerosis with nanotheranosticsNF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic ImplicationsCrocin suppresses LPS-stimulated expression of inducible nitric oxide synthase by upregulation of heme oxygenase-1 via calcium/calmodulin-dependent protein kinase 4Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis.Toward Carbon Monoxide-Based Therapeutics: Critical Drug Delivery and Developability IssuesAntimicrobial Activity of the Manganese Photoactivated Carbon Monoxide-Releasing Molecule [Mn(CO)3(tpa-κ(3)N)](+) Against a Pathogenic Escherichia coli that Causes Urinary Infections.The role of T helper (TH)17 cells as a double-edged sword in the interplay of infection and autoimmunity with a focus on xenobiotic-induced immunomodulation.Carbon monoxide and the CNS: challenges and achievements.Chromo-fluorogenic probes for carbon monoxide detection.A click-and-release approach to CO prodrugs.Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects.Capturing the photo-signaling state of a photoreceptor in a steady-state fashion by binding a transition metal complex.Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis.Carbon Monoxide Inhibits Islet Apoptosis via Induction of Autophagy.Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis.
P2860
Q26778311-EF947003-8984-4A85-BD95-D345DB689314Q28078299-3B47BE4C-C8BC-46A5-ACE1-B97CBD4D3F6EQ30413038-6A1233C4-00C4-4620-9F51-350A97B90229Q36574735-4BDF144F-66FF-49E6-B93D-158897C8C504Q36584960-4B7A1ACD-8CBA-4F85-A532-2E9051A56BE9Q36925719-C2C35A89-D6DB-40DA-9D20-80F5BFF35812Q38154889-D27B3ECB-0DA8-4125-9982-91EEDF876059Q38206577-BEAE59F8-FD70-4441-9F19-BA40108AB356Q38793934-9534AF98-DBBE-4A53-AFBF-EB6E3919E6CBQ38942209-C7F8766B-ADFE-405C-8F38-D9787E4C071CQ39027987-52DD8C6A-404D-4F4E-86B1-6661FA063D1AQ47736109-51FC0369-BE15-4432-BD22-8C120BB844B5Q47790004-F10FFC01-28AD-4B5C-9F84-6174B71E36E2Q47926738-180B218E-31A8-4F33-9CD0-55C2978C0794Q48149436-EEBCC125-BA5D-4B54-A018-DEDFFC2C75AC
P2860
Therapeutic potential of carbon monoxide in multiple sclerosis
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Therapeutic potential of carbon monoxide in multiple sclerosis
@ast
Therapeutic potential of carbon monoxide in multiple sclerosis
@en
Therapeutic potential of carbon monoxide in multiple sclerosis
@nl
type
label
Therapeutic potential of carbon monoxide in multiple sclerosis
@ast
Therapeutic potential of carbon monoxide in multiple sclerosis
@en
Therapeutic potential of carbon monoxide in multiple sclerosis
@nl
prefLabel
Therapeutic potential of carbon monoxide in multiple sclerosis
@ast
Therapeutic potential of carbon monoxide in multiple sclerosis
@en
Therapeutic potential of carbon monoxide in multiple sclerosis
@nl
P2093
P2860
P3181
P1476
Therapeutic potential of carbon monoxide in multiple sclerosis
@en
P2093
C. C. Romao
F. Nicoletti
G. Garotta
K. Mangano
V. Perciavalle
P2860
P304
P3181
P356
10.1111/J.1365-2249.2011.04491.X
P407
P577
2012-02-01T00:00:00Z